The hay wells syndrome-derived TAp63αQ540L mutant has impaired transcriptional and cell growth regulatory activity

Cell Cycle

Volumn 5, Issue 1, 2006, Pages 78-87

  Lo Iacono, Marco ^a   Di Costanzo, Antonella ^b   Calogero, Raffaele A ^a   Mansueto, Gelsomina ^b   Saviozzi, Silvia ^a   Crispi, Stefanie ^c   Pollice, Alessandra ^b   La Mantia, Girolama ^b   Calabrò, Viola ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

Genetic alteration; Hay Wells syndrome; Microarray; TAp63 ; Transcription regulation

Indexed keywords

MUTANT PROTEIN; PROTEIN P63;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EPITHELIUM; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GROWTH REGULATION; HAY WELLS SYNDROME; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROTEIN EXPRESSION;

EID: 33645290551     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.1.2268     Document Type: Article

References (55)

1. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398:708-13.
2. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398:714-8.
3. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 2004; 18:126-31, [see comment].
4. Koster MI, Roop DR. The role of p63 in development and differentiation of the epidermis. Journal of Dermatological Science 2004; 34:3-9.
5. Koster MI, Roop DR. Transgenic mouse models provide new insights into the role of p63 in epidermal development. Cell Cycle 2004; 3:411-3.
6. Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H, Maria Lena A, Candi E, Terrinoni A, Valeria Catani M, Oren M, Melino G, Krammer PH, Stremmel W, Muller M. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 2005; 24:2458-71.
7. Iwakuma T, Lozano G, Flores ER. Li-Fraumeni syndrome: A p53 family affair. Cell Cycle 2005; 4:865-7.
8. Zangen R, Ratovitski E, Sidransky D. DeltaNp63alpha levels correlate with clinical tumor response to cisplatin. Cell Cycle 2005; 4:1313-5.
9. Blandino G, Dobbelstein M. Li-Fraumeni syndrome: A p53 family affair. Cell Cycle 2004; 3:865-7.
10. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2:305-16.
11. Fomenkov A, Huang YP, Topaloglu O, Brechman A, Osada M, Fomenkova T, Yuriditsky E, Trink B, Sidransky D, Ratovitski E. P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome. J Biol Chem 2003; 278:23906-14.
12. Chi SW, Ayed A, Arrowsmith CH. Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO Journal 1999; 18:4438-45.
13. Serber Z, Lai HC, Yang A, Ou HD, Sigal MS, Kelly AE, Darimont BD, Duijf PH, Van Bokhoven H, McKeon F, Dotsch V. A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol Cell Biol 2002; 22:8601-11.
14. Bakkers J, Camacho-Carvajal M, Novak M, Kramer C, Danger B, Hammerschmidt M. Destabilization of ΔNp63α by Nedd4-mediated ubiquitination Ubc9-mediated sumoylation, and its implications on dorsoventral patterning of the zebrafish embryo. Cell Cycle 2005; 4:790-800.
15. Calabro V, Mansueto G, Parisi T, Vivo M, Calogero RA, La Mantia G. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J Biol Chem 2002; 277:2674-81.
16. Calabro V, Mansueto G, Santoro R, Gentilella A, Pollice A, Ghioni P, Guerrini L, La Mantia G. Inhibition of p63 transcriptional activity by p14ARF: Functional and physical link between human ARF tumor suppressor and a member of the p53 family. Mol Cell Biol 2004; 24:8529-40.
17. Ghioni P, D'Alessandra Y, Mansueto G, Jaffray E, Hay RT, La Mantia G, Guerrini L. The protein stability and transcriptional activity of p63α are regulated by SUMO-1 conjugation. Cell Cycle 2005; 4:183-90.
18. Huang YP, Wu G, Guo Z, Osada M, Fomenkov A, Ratovitski EA. Altered sumoylation of p63α contributes to the Split-hand/foot malformation phenotype. Cell Cycle 2004; 3:1587-96.
19. Westfall MD, Joyner AS, Barbieri CE, Livingstone M, Pietenpol JA. Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of ΔNP63α. Cell Cycle 2005; 4:710-6.
20. Brunner HG, Hamel BC, Van Bokhoven H. The p63 gene in EEC and other syndromes. J Med Genet 2002; 39:377-81.
21. van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, Vanmolkot KR, van Beusekom E, van Beersum SE, Celli J, Merkx GF, Tenconi R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beemer FA, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JR, Neri G, Brunner HG. p63 gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Human Genet 2001; 69:481-92.
22. McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR, Wessagowit V, Kelly A, Atherton DJ, Griffiths WA, Orlow SJ, van Haeringen A, Ausems MG, Yang A, McKeon F, Bamshad MA, Brunner HG, Hamel BC, van Bokhoven H. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Human Mol Genet 2001; 10:221-9.
23. Huang YP, Kim Y, Li Z, Fomenkov T, Fomenkov A, Ratovitski EA. Stabilization of p63 and modulation of Notch signaling. Cell Cycle 2005; 4:1440-7.
24. Hay RJ, Wells RS. The syndrome of ankyloblepharon, ectodermal defects and cleft lip and palate: An autosomal dominant condition. Brit J Dermatol 1976; 94:277-89.
25. Ghioni P, Bolognese F, Duijf PH, Van Bokhoven H, Mantovani R, Guerrini L. Complex transcriptional effects of p63 isoforms: Identification of novel activation and repression domains. Mol Cell Biol 2002; 22:8659-68.
26. Parisi T, Pollice A, Di Cristofano A, Calabro V, La Mantia G. Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors. Biochem Biophys Res Commun 2002; 291:1138-45.
27. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 2003; 23:2264-76.
28. Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays proceedings of RECOMB. 2004.
29. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19:185-93.
30. von Heydebreck A, Huber W, Gentleman R. Differential expression with the bioconductor project. 2004.
31. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 2001; 98:5116-21, [erratum appears in Proc Natl Acad Sci USA 2001 Aug 28;98:10515.
32. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: Gene-centered information at NCBI. Nucleic Acids Res 2005; 33:D54-8.
33. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004; 5.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (Duluth) 2001; 25:402-8.
35. Dohn M, Zhang S, Chen X. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 2001; 20:3193-205.
36. Koutsodontis G, Vasilaki E, Chou WC, Papakosta P, Kardassis D. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: Importance for the regulation of genes involved in cell-cycle arrest and apoptosis. Biochem J 2005; 15:443-55.
37. Phelps M, Darley M, Primrose JN, Blaydes JP. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells. Cancer Res 2003; 63:2616-23.
38. Ying H, Chang DL, Zheng H, McKeon F, Xiao Z. DNA-binding and transactivation activities are essential for TAp63 protein degradation. Mol Cell Biol 2005; 25:6154-64.
39. Beretta C, Chiarelli A, Testoni B, Mantovani R, Guerrini L. Regulation of the cyclin-dependent kinase inhibitor p57kip2 expression by p63. Cell Cycle 2005; 4:1623-9.
40. Wu G, Osada M, Guo Z, Fomenkov A, Begum S, Zhao M, Upadhyay S, Xing M, Wu F, Moon C, Westra WH, Koch WM, Mantovani R, Califano JA, Ratovitski E, Sidransky D, Trink B. DeltaNp63alpha upregulates the Hsp70 gene in human cancer. Cancer Res 2005; 65:758-66.
41. Nishi H, Senoo M, Nishi KH, Murphy B, Rikiyama T, Matsumura Y, Habu S, Johnson AC. p53 Homologue p63 represses epidermal growth factor receptor expression. J Biol Chem 2001; 276:41717-24.
42. Ishisaki Z, Takaishi M, Furuta I, Huh N. Calmin, a protein with calponin homology and transmembrane domains expressed in maturing spermatogenic cells. Genomics 2001; 74:172-9.
43. Rehli M, Krause SW, Kreutz M, Andreesen R. Carboxypeptidase M is identical to the MAX. 1 antigen and its expression is associated with monocyte to macrophage differentiation. J Biol Chem 1995; 270:15644-9.
44. Uchida K, Chaudhary LR, Sugimura Y, Adkisson HD, Hruska KA. Proprotein convertases regulate activity of prostate epithelial cell differentiation markers and are modulated in human prostate cancer cells. J Cell Biochem 2003; 88:394-9.
45. Vasavada TK, DiAngelo JR, Duncan MK. Developmental expression of Pop1/Bves. J Histochem Cytochem 2004; 52:371-7.
46. Clase KL, Mitchell PJ, Ward PJ, Dorman CM, Johnson SE, Hannon K. FGF5 stimulates expansion of connective tissue fibroblasts and inhibits skeletal muscle development in the limb. Dev Dynam 2000; 219:368-80.
47. Collombat P, Mansouri A, Hecksher-Sorensen J, Serup P, Krull J, Gradwohl G, Gruss P. Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev 2003; 17:2591-603.
48. Hebert JM, Basilico C, Goldfarb M, Haub O, Martin GR. Isolation of cDNAs encoding four mouse FGF family members and characterization of their expression patterns during embryogenesis. Dev Biol 1990; 138:454-63.
49. Yoshihara S, Omichi K, Yanazawa M, Kitamura K, Yoshihara Y. Arx homeobox gene is essential for development of mouse olfactory system. Development 2005; 132:751-62.
50. Tan M, Wang Y, Guan K, Sun Y. PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Nat Acad Sci USA 2000; 97:109-14.
51. Wong J, Li PX, Klamut HJ. A novel p53 transcriptional repressor element (p53TRE) and the asymmetrical contribution of two p53 binding sites modulate the response of the placental transforming growth factor-beta promoter to p53. J Biol Chem 2002; 277:26699-707.
52. Ripley AN, Chang MS, Bader DM. Bves is expressed in the epithelial components of the retina, lens, and cornea. Invest Ophthalmol Visual Sci 2004; 45:2475-83.
53. Osler ME, Bader DM. Bves expression during avian embryogenesis. Dev Dynamics 2004; 229:658-67.
54. Wang ZL, Inokuchi T, Ikeda H, Baba TT, Uehara M, Kamasaki N, Sano K, Nemoto TK, Taguchi T. Collagen-binding heat shock protein HSP47 expression during healing of fetal skin wounds. Int J Oral Maxillofacial Surg 2002; 31:179-84.
55. Okuyama R, LeFort K, Dotto GP. A dynamic model of keratinocyte stem cell renewal and differentiation: Role of the p21WAF1/Cip1 and Notch1 signaling pathways. J Invest Dermatol Symp Proc 2004; 9:248-52.